ClinicalTrials.gg
RecruitingNCT07856498Updated Oct 8, 2026

Pain Catastrophizing, Fear of Movement, and Physical Activity in Postmenopausal Women With Chronic Low Back Pain

An observational study in Low Back Pain and Postmenopause Women, sponsored by Istanbul Medipol University Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Istanbul Medipol University Hospital · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 8, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
150
Ages
45 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Low Back Pain by Istanbul Medipol University Hospital — 2 open to participants now, 3 under way, none of them phase 3. Low Back Pain · Istanbul Medipol University Hospital.

Started
2026
with 1 other
Observational
2 of 12
2 open now
Registered
12th of 12
by date

Among the 12 studies in Low Back Pain by Istanbul Medipol University Hospital, this one is one of 2 that started in 2026, is one of 2 observational ones, and was the 12th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

2 of the 12 studies in Low Back Pain by Istanbul Medipol University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 45 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Low Back Pain by Istanbul Medipol University Hospital, or all of them as a file.
02

Study summary

This observational study aims to examine the relationships between pain catastrophizing, fear of movement, and physical activity in postmenopausal women with chronic nonspecific low back pain. Pain catastrophizing refers to negative thoughts and feelings about pain, while fear of movement refers to concerns that movement may cause pain or injury.

The study will include 150 naturally postmenopausal women aged 45-65 years who have experienced nonspecific low back pain for at least three months. Participants will attend a single face-to-face assessment conducted by a trained physiotherapist. Questionnaires will assess physical activity, pain catastrophizing, fear of movement, low back pain intensity, disability symptoms. Functional mobility and lower-limb functional performance will be assessed using the Timed Up and Go test and the 30-second chair stand test.

The primary objective is to examine the joint association of pain catastrophizing and fear of movement with physical activity, accounting for relevant clinical and psychological factors. Secondary objectives concern disability and physical performance. No treatment will be assigned as part of the study.

Read the detailed description

Average low back pain intensity during the previous seven days will be assessed using an 11-point Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (the worst imaginable pain). The assessment will refer specifically to the low back region.

03

Conditions studied

  • Low Back Pain
  • Postmenopause Women

Browse trials for

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Naturally postmenopausal women aged 45-65 years with nonspecific low back pain lasting at least three months. Natural postmenopause is defined as at least 12 consecutive months without menstruation, without another apparent physiological or pathological cause or a clinical intervention explaining amenorrhea. Nonspecific low back pain will be confirmed by physician assessment. Eligible women will be invited consecutively to participate in the study, with a target enrollment of 150 participants.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 45 to 65 years.
  • Natural , defined as at least 12 consecutive months without menstruation, with no other apparent physiological or pathological cause and no clinical intervention explaining the absence of menstruation, confirmed by medical history and available medical records.
  • Low back pain lasting at least three months, with no specific underlying cause identified through physician assessment.
  • Ability to read and understand Turkish, provide , and follow the assessment instructions.
  • Provision of written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Surgically or medically induced menopause.
  • Active , or a vertebral compression fracture, infection, inflammatory spinal disease, or another specific condition explaining the low back pain.
  • Physician-confirmed radiculopathy, a marked neurological deficit, or lumbar spinal stenosis accompanied by neurogenic claudication.
  • A severe neurological, rheumatological, or orthopedic disorder, or major surgery within the previous six months, that prevents safe or valid assessment.
  • Cardiopulmonary disease or an acute medical condition that substantially limits physical activity or makes the physical performance assessments unsafe.
  • Significant cognitive impairment or an acute or severe psychiatric condition that prevents valid or understanding of the assessment instructions.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Postmenopausal Women With Chronic Nonspecific Low Back Pain

    Naturally postmenopausal women aged 45-65 years with nonspecific low back pain lasting at least three months. Participants will undergo a single face-to-face assessment by a trained physiotherapist. Questionnaires will assess physical activity, pain catastrophizing, kinesiophobia, low back pain intensity, disability symptoms. Functional mobility and lower-limb functional performance will be assessed using the Timed Up and Go test and the 30-second chair stand test. No treatment will be assigned as part of the study.

06

What researchers measure

Primary outcomes

  1. Total Physical Activity Assessed by the International Physical Activity Questionnaire Short Form

    Self-reported physical activity will be assessed using the Turkish version of the International Physical Activity Questionnaire Short Form (IPAQ-SF). Walking, moderate-intensity activity, and vigorous-intensity activity during the previous seven days will be scored according to the standard IPAQ scoring protocol and summed to obtain total MET-minutes per week. Sitting time will be recorded separately and will not contribute to the total physical activity score. Higher values indicate greater reported physical activity.

    Time frame: At the single assessment visit (Day 1), referring to physical activity during the previous 7 days.

Secondary outcomes

  1. Low Back Pain-Related Disability Assessed by the Oswestry Disability Index

    Low back pain-related disability will be assessed using the Turkish version of the Oswestry Disability Index. The questionnaire consists of 10 sections scored from 0 to 5. The total score will be expressed as a percentage of the maximum possible score for the valid, completed sections, following the scoring rules of the version used. Scores range from 0% to 100%, with higher scores indicating greater disability. Time Frame:

    Time frame: At the single assessment visit (Day 1).

  2. Functional Lower-Limb Performance Assessed by the 30-Second Chair Stand Test

    Functional lower-limb performance will be assessed by the number of chair stands completed during one recorded 30-second trial. Participants will use an armless chair approximately 43 cm high, with their feet on the floor and arms crossed over the chest. A final repetition will be counted if the participant is more than halfway through standing when the time ends. Higher counts indicate better performance. Inability to stand without arm support will be scored as zero. Tests that cannot be started or must be stopped for safety reasons will be recorded as missing, with the reason documented.

    Time frame: At the single assessment visit (Day 1).

  3. Functional Mobility Assessed by the Timed Up and Go Test

    Functional mobility will be assessed by the time, in seconds, required to rise from a standard armchair, walk 3 meters at the usual pace, turn, return to the chair, and sit down. Timing will begin with the start command and end when the participant is seated again. Participants will wear their usual footwear, and use of a customary walking aid will be documented. Longer completion times indicate poorer functional mobility.

    Time frame: At the single assessment visit (Day 1).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — There is currently no plan to share individual participant data. Study findings will be reported in aggregate form.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 2, 2026
StartActual
Sep 28, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 8, 2026
Sites
Istanbul Medipol University is now Recruiting
Oct 8, 2026
Registered
First appeared on the registry
Oct 2, 2026
Show all 2 updates
  1. Oct 8, 2026
    Not yet recruiting→Recruiting
    Istanbul Medipol University is now Recruiting
    + 2 other changes: verification date and date precision
  2. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07856498
Responsible party
gizem boztas (Assistant professor, Istanbul Medipol University Hospital) — Principal investigator
First posted
Oct 2, 2026
Start date
Sep 28, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Oct 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion